Login Register Cart 0
Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Pharmacovigilance in Herbal Drugs: A Challenge

Author(s): Kemisha Sanghvi, Chandrashekar Kodangala Subraya*, Vasudev Pai, Aswatha Ram Holavanna Halli Nanjundaiah and Vijayanarayana Kunhikatta

Volume 18, Issue 2, 2023

Published on: 28 June, 2022

Page: [138 - 142] Pages: 5

DOI: 10.2174/1574886317666220428125943

Price: $65

Abstract

There is a growing awareness of a disease at many levels, its treatment, and treatment outcomes including side effects. Alternative therapy techniques, herbal medicines and formulations are extensively acknowledged and practiced in India and around the world. Herbal medicine is usually considered being safe regardless of the absence of scientific evidence to support its claims. Several issues concerning the methods in which herbal medications are labelled, evaluated, sourced, and used are connected to herbal medicine. Herbal therapeutics in the management and treatment of diabetes, rheumatism, hepatic disorders and other mild to chronic diseases and disorders are widely accepted. However, the adversities are difficult to recognize. The idea that the nature is safe and may be taken without the prescription of a physician has resulted in widespread self-medication across the world, sometimes with disappointing results, side effects, or unpleasant after-effects. The existing pharmacovigilance paradigm and its accompanying tools were created in connection with synthetic medicines. Nevertheless, adopting these approaches to keep records of herbal medications’ safety poses a distinct challenge. This might be due to the variations in the usage of non-traditional medicines, which can offer unique toxicological issues whether taken alone or in conjunction with other medications. The goal of pharmacovigilance is to identify, analyse, explain, and minimize the adverse reactions and other drug-related complications associated with herbal, traditional, and complementary medications. Systematic pharmacovigilance is required to collect accurate data on the safety of herbal medications to create adequate guidelines for effective and safe usage.

Keywords: Pharmacovigilance, herbal medicine, challenges, drug safety, adverse drug reaction (ADR), dietary supplements.

« Previous Next »
Graphical Abstract

[1]
Muriithi DN, Mokaya D, Muturi SK. Adverse drug reaction occurrence, reporting and associated factors among patients in selected hospitals in Kirinyaga County, Kenya. Pharmaceutical Journal of Kenya 2020; 24(3): 53-8.
[2]
Shaw D, Ladds G, Duez P, Williamson E, Chan K. Pharmacovigilance of herbal medicine. J Ethnopharmacol 2012; 40(3): 513-8.
[http://dx.doi.org/10.1016/j.jep.2012.01.051]
[3]
Ajanal M, Nayak S, Pyasad BS, Kadam A. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview. Jyang Pharm 2013; 5(4): 116-20.
[http://dx.doi.org/10.1016/j.jyp.2013.10.001]
[4]
Barnes J. Pharmacovigilance of herbal medicines: A UK perspective. Drug Saf 2003; 26(12): 829-51.
[http://dx.doi.org/10.2165/00002018-200326120-00001] [PMID: 12959628]
[5]
Vijay DG, Biren NS, Sonal PM, Shailju GG. Herbal Drug Technology. Nagpur, India: ABD Publishers and Printers (P) LTD. 2021; pp. 2-3.
[6]
Committee on safety drugs The Medicines Act. London: The Stationery Office 1968.
[7]
Commission of the European Communities. Proposal for amending the directive 2001/83/EC as regards traditional herbal medicinal products. In: 2002/0008 (COD). European Group: Brussels 2002.
[8]
Commission of the European Communities. Amended proposal or a directive of the European parliament and of the council amending the directive 2001/83/EC as regards traditional herbal medicina products. In: 2002/0008 (COD). Brussels: European commission 2003.
[9]
Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 2010; 243(2): 198-216.
[http://dx.doi.org/10.1016/j.taap.2009.12.005] [PMID: 20018204]
[10]
Wal P, Wal A, Gupta S, Sharma G, Rai A. Pharmacovigilance of herbal products in India. J Young Pharm 2011; 3(3): 256-8.
[http://dx.doi.org/10.4103/0975-1483.83780] [PMID: 21897669]
[11]
Sandeep S, Dinesh KC, Neeraj KS, Sharma IP. Pharmacovigilance of herbal medicines: Current state and future directions. 2011; 7(25): 69-73.
[http://dx.doi.org/10.4103/0973-1296.75905]
[12]
Palaian S. Pharmacovigilance Practices and Activities: Issues, Challenges, and Future Direction. London: Academic Press 2017; pp. 145-62.
[http://dx.doi.org/10.1016/B978-0-12-811228-1.00009-1]
[13]
Haripriya S, Syamala M, Mujeebuddin CS. Pharmacovigilance system in India. Int J Pharm Sci Rev Res 2020; 63(1): 73-80.
[14]
Loew D, Kaszkin M. Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 2002; 16(8): 705-11.
[http://dx.doi.org/10.1002/ptr.1248] [PMID: 12458470]
[15]
Mann RD, Andrews EF. Pharmacovigilance. John Wiley & Sons, Ltd 2007; pp. 1-3.
[16]
Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: Face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45(5): 496-500.
[http://dx.doi.org/10.1046/j.1365-2125.1998.00715.x] [PMID: 9643624]

Rights & Permissions Print Cite
Article Metrics
41
2
© 2024 Bentham Science Publishers | Privacy Policy